Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort

Silvia Ingala(University of Geneva), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Lisa Vermunt(Amsterdam Neuroscience), Joanna M. Wardlaw(University of Edinburgh), Gaël Chételat(Inserm), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Luigi Lorenzini(Amsterdam Neuroscience), Kaj Blennow(Sahlgrenska University Hospital), Viktor Wottschel(University of Geneva), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Wiesje M. van der Flier(Amsterdam Neuroscience), Craig Ritchie(Western General Hospital), José Luís Molinuevo(Pasqual Maragall Foundation), Henk Mutsaerts(Amsterdam Neuroscience), Michael Ewers(German Center for Neurodegenerative Diseases), Ilaria Vergari(Amsterdam Neuroscience), Sven Haller(Ulsan College), Larissa A Masselink(Amsterdam Neuroscience), Adam Waldman(Royal Society of Edinburgh), Juan Domingo Gispert(Lund University), Graciela Muñiz‐Terrera(University of Edinburgh), Alle Meije Wink(University of Cambridge), Karen Ritchie(Research Medical Center), Mark E. Schmidt(Janssen (Belgium)), Casper de Boer(Amsterdam Neuroscience), Adam J. Schwarz(Eli Lilly (United States)), Robin Wolz(Ixico (United Kingdom)), Carol Di Perri(University of Liège)
Alzheimer s & Dementia
April 3, 2021
Cited by 101


Related Papers